DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1829, Issue 10, 2013, Pages 1102-1110

  Iio, Akio ^a,b   Takagi, Takeshi ^c   Miki, Kohei ^c   Naoe, Tomoki ^d   Nakayama, Atsuo ^b   Akao, Yukihiro ^a  

^a GIFU UNIVERSITY   (Japan)

^b INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

DDX6; MiR 143; MiR 145; NCR143 145; P bodies

Indexed keywords

DEAD BOX PROTEIN; DEAD BOX PROTEIN 6; MICRORNA 143; MICRORNA 145; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENOMIC INSTABILITY; HALF LIFE TIME; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VITRO STUDY; NONSENSE MEDIATED MRNA DECAY; ONCOGENE C MYC; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA DEGRADATION; RNA EXTRACTION; RNA INTERFERENCE; RNA PROCESSING; RNA STABILITY; STOMACH CANCER; UPREGULATION; WESTERN BLOTTING;

5′-3′ EXORIBONUCLEASE 1; 7-METHYLGUANOSINE; 7MG; ACTB; ACTD; ACTINOMYCIN D; AGO1; AGO2; ARE; ARGONAUTE 1; ARGONAUTE 2; AU-RICH ELEMENTS; BETA-ACTIN; CHX; CRM1; CYCLOHEXIMIDE; DAPI; DCP1 DECAPPING ENZYME HOMOLOG A; DCP1A; DDX17; DDX5; DDX6; DEAD-BOX RNA HELICASE 17; DEAD-BOX RNA HELICASE 5; DEAD-BOX RNA HELICASE 6; DIAMIDINO-2-PHENYLINDOLE; EDC3; ENHANCER OF MRNA DECAPPING 3 HOMOLOG; GAPDH; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS; HIF1A; HNRNPS; HYPOXIA INDUCIBLE FACTOR 1 ALPHA SUBUNIT; IFN-Β; IGG; IMMUNOGLOBULIN G; IMPORTAZOLE; IMPORTIN FAMILY NUCLEAR EXPORT RECEPTOR; INTERFERON-BETA; IPZ; LEPTOMYCIN B; LIPOPOLYSACCHARIDE; LMB; LPS; MICRORNA; MICRORNA PRECURSORS; MICRORNA-143; MICRORNA-143/145 HOST NON-CODING RNA GENE; MICRORNA-145; MIR-143; MIR-145; MIRNA; NC; NCR143/145; NEGATIVE CONTROL; NMD; NON-SPLICED NCR143/145; NONSENSE-MEDIATED MRNA DECAY; NSNCR143/145; P-BODIES; POLYVINYLIDENE FLUORIDE; PRE-MIRNAS; PRI-MIRNAS; PRIMARY MICRORNA TRANSCRIPTS; PROCESSING BODIES; PVDF; R15-LOX; RACE; RADIOIMMUNOPRECIPITATION ASSAY; RAPID AMPLIFICATION OF CDNA ENDS; RETICULOCYTE 15-LIPOXIGENASE; RIPA; RISC; RN7SL1; RNA 7SL CYTOPLASMIC 1; RNA-INDUCED SILENCING COMPLEXES; RNU6B; TNF-Α; TUMOR NECROSIS FACTOR-ALPHA; U22 SNORNA HOST GENE; U6 SMALL NUCLEAR B RNA; UHG; XRN1;

BLOTTING, WESTERN; CELLS, CULTURED; DEAD-BOX RNA HELICASES; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; LUCIFERASES; MALE; MICRORNAS; MONOCYTES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, LONG NONCODING; RNA, MESSENGER; RNA, SMALL INTERFERING; STOMACH NEOPLASMS;

EID: 84883224158     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2013.07.010     Document Type: Article

References (55)

1. Siomi H., Siomi M.C. Posttranscriptional regulation of MicroRNA biogenesis in animals. Mol. Cell 2010, 38:323-332.
2. Akao Y., Nakagawa Y., Naoe T. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol. Rep. 2006, 16:845-850.
3. Akao Y., Nakagawa Y., Naoe T. MicroRNA-143 and -145 in colon cancer. DNA Cell Biol. 2007, 26:311-320.
4. Takagi T., Iio A., Nakagawa Y., Naoe T., Tanigawa N., Akao Y. Decreased expression of microRNAs-143 and -145 in human gastric cancers. Oncology 2009, 77:12-21.
5. Akao Y., Nakagawa Y., Kitade Y., Kinoshita T., Naoe T. Down-regulation of micoRNAs-143 and -145 in B-cell malignancies. Cancer Sci. 2007, 98:1914-1920.
6. Michael M.Z., O' Connor S.M., van Holst Pellekaan N.G., Young G.P., James R.J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 2003, 1:882-891.
7. Akao Y., Nakagawa Y., Hirata I., Iio A., Itoh T., Kojima K., Nakashima R., Kitade Y., Naoe T. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther. 2010, 17:398-408.
8. Kamatani A., Nakagawa Y., Hirata I., Akao Y. Down-regulation of anti-oncomir miR-143/-145 cluster occurs before APC gene aberration in the development of colorectal tumors. Med. Mol. Morph. 2013, (in press) http://rd.springer.com/article/10.1007%2Fs00795-013-0020-5.
9. Iio A., Nakagawa Y., Hirata I., Naoe T., Akao Y. Identification of non-coding RNAs embracing microRNA-143/145 cluster. Mol. Cancer 2010, 9:136.
10. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., Lee T.H., Miano J.M., Ivey K.N., Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
11. Kent O.A., Chivukula R.R., Mullendore M., Wentzel E.A., Feldmann G., Lee K.H., Liu S., Leach S.D., Maitra A., Mendell J.T. Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev. 2010, 24:2754-2759.
12. Thomson J.M., Newman M., Parker J.S., Morin-Kensicki E.M., Wright T., Hammond S.M. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 2006, 20:2202-2207.
13. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., Miyazono K. Modulation of microRNA processing by p53. Nature 2009, 460:529-533.
14. Akao Y., Seto M., Takahashi T., Saito M., Utsumi K.R., Nakazawa S., Ueda R. Rearrangements on chromosome 11q23 in hematopoietic tumor-associated t (11; 14) and t (11; 19) translocations. Cancer Res. 1991, 51:6708-6711.
15. Akao Y., Matsumoto K., Ohguchi K., Nakagawa Y., Yoshida H. Human DEAD-box/RNA unwindase rck/p54 contributes to maintenance of cell growth by affecting cell cycle in cultured cells. Int. J. Oncol. 2006, 29:41-48.
16. Lin F., Wang R., Shen J.J., Wang X., Gao P., Dong K., Zhang H.Z. Knockdown of RCK/p54 expression by RNAi inhibits proliferation of human colorectal cancer cells in vitro and in vivo. Cancer Biol. Ther. 2008, 7:1669-1676.
17. Akao Y. A role of DEAD-box RNA helicase rck/p54 in cancer cells. Cur. Drug Ther. 2009, 4:29-37.
18. Minshall N., Standart N. The active form of Xp54 RNA helicase in translational repression is an RNA-mediated oligomer. Nucleic Acids Res. 2004, 32:1325-1334.
19. Andrei M.A., Ingelfinger D., Heintzmann R., Achsel T., Rivera-Pomar R., Lührmann R. A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies. RNA 2005, 11:717-727.
20. Jangra R.K., Yi M., Lemon S.M. DDX6 (Rck/p54) required for efficient hepatitis C virus replication but not for internal ribosome entry site-directed translation. J. Virol. 2010, 84:6810-6824.
21. Saito K., Kondo E., Matsushita M. MicroRNA 130 family regulates the hypoxia response signal through the P-body protein DDX6. Nucleic Acids Res. 2011, 39:6086-6099.
22. Naarmann I.S., Harnisch C., Müller-Newen G., Urlaub H., Ostareck-Lederer A., Ostareck D.H. DDX6 recruits translational silenced human reticulocyte 15-lipoxigenase mRNA to RNP granules. RNA 2010, 16:2189-2204.
23. Chu C.Y., Rana T.M. Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54. PLoS Biol. 2006, 4:e210.
24. Cifuentes D., Xue H., Taylor D.W., Patnode H., Mishima Y., Cheloufi S., Ma E., Mane S., Hannon G.J., Lawson N.D., Giraldez A.J. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 2010, 328:1694-1698.
25. Ferraiuolo M.A., Basak S., Dostie J., Murray E.L., Schoenberg D.R., Sonenberg N. A role for the eIF4E-binding protein 4E-T in P-body formation and mRNA decay. J. Cell Biol. 2005, 170:913-924.
26. Akao Y., Seto M., Yamamoto K., Iida S., Nakazawa S., Inazawa J., Abe T., Takahashi T., Ueda R. The RCK gene associated with t (11:14) translocation is distinct from the MLL/ALL-1 gene with t (4:11) and t (11:19) translocations. Cancer Res. 1992, 52:6083-6087.
27. Akao Y., Mizoguchi H., Ohishi N., Yagi K. Growth inhibition by overexpression of human DEAD box protein rck/p54 in cells of a guinea pig cell line. FEBS Lett. 1998, 429:279-283.
28. Nakagawa Y., Morikawa H., Hirata I., Shiozaki M., Matsumoto A., Maemura K., Nishikawa T., Niki M., Tanigawa N., Ikegami M., Katsu K., Akao Y. Overexpression of rck/p54, a DEAD box protein, in human colorectal tumours. Br. J. Cancer 1999, 80:914-917.
29. Hashimoto K., Nakagawa Y., Morikawa H., Niki M., Egashira Y., Hirata I., Katsu K., Akao Y. Co-expression of DEAD box protein rck/p54 and c-myc protein in human colorectal adenomas and the relevance of their expression in cultured cell lines. Carcinogenesis 2001, 22:1965-1970.
30. Miyaji K., Nakagawa Y., Matsumoto K., Yoshida H., Morikawa H., Hongou Y., Arisaka Y., Kojima H., Inoue T., Hirata I., Katsu K., Akao Y. Overexpression of a DEAD box/RNA helicase protein, rck/p54, in human hepatocytes from patients with hepatitis C virus-related chronic hepatitis and its implication in hepatocellular carcinogenesis. J. Viral Hepat. 2003, 10:241-248.
31. Kent O.A., Fox-Talbot K., Halushka M.K. RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets. Oncogene 2013, 32:2576-2585.
32. Chang T.C., Yu D., Lee Y.S., Wentzel E.A., Arking D.E., West K.M., Dang C.V., Thomas-Tikhonenko A., Mendell J.T. Widspread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 2008, 40:43-50.
33. Frischmeyer P.A., Dietz H.C. Nonsense-mediated mRNA decay in health and disease. Hum. Mol. Genet. 1999, 8:1893-1900.
34. Sachdeva M., Zhu S., Wu F., Wu H., Walla V., Kumar S., Elble R., Watabe K., Mo Y.Y. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl. Sci. U.S.A. 2009, 106:3207-3212.
35. Michlewski G., Cceres J.F. Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis. Nat. Struct. Mol. Biol. 2010, 17:1011-1018.
36. Fuller-Pace F.V., Ali S. The DEAD box RNA helicases p68 (Ddx5) and p72 (Ddx17): novel transcriptional co-regulators. Biochem. Soc. Trans. 2008, 36:609-612.
37. Smillie D.A., Sommerville J. RNA helicase p54 (DDX6) is a shuttling protein involved in nuclear assembly of stored mRNP particles. J. Cell Sci. 2002, 115:395-407.
38. Coller J., Parker R. General translational repression by activators of mRNA decapping. Cell 2005, 122:875-886.
39. Sheth U., Parker R. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 2003, 300:805-808.
40. Carter M.S., Doskow J., Morris P., Li S., Nhim R.P., Sandstedt S., Wilkinson M.F. A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J. Biol. Chem. 1995, 270:28995-29003.
41. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell. Signal. 2001, 13:85-94.
42. Pauley K.M., Satoh M., Pauley B.A., Dominguez-Gutierrez P.R., Wallet S.M., Holliday L.S., Cha S., Reeves W.H., Chan E.K. Formation of GW/P bodies as marker for microRNA-mediated regulation of innate immune signaling in THP-1 cells. Immunol. Cell Biol. 2010, 88:205-212.
43. Xu N., Papagiannakopoulos T., Pan G., Thomson J.A., Kosik K.S. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009, 137:647-658.
44. Witwer K.W., Sisk J.M., Gama L., Clements J.E. MicroRNA regulation of IFN-beta protein expression: rapid and sensitive modulation of the innate immune response. J. Immunol. 2001, 184:2369-2376.
45. Akao Y., Yoshida H., Matsumoto K., Matsui T., Hogetu K., Tanaka N., Usukura J. A tumour-associated DEAD-box protein, rck/p54 exhibits RNA unwinding activity toward c-myc RNAs in vitro. Genes Cells 2003, 8:671-676.
46. Yoon J.H., Abdelmohsen K., Srikantan S., Yang X., Martindale J.L., De S., Huarte M., Zhan M., Becker K.G., Gorospe M. LincRNA-p21 suppresses target mRNA translation. Mol. Cell 2012, 47:648-655.
47. Choe J., Cho H., Lee H.C., Kim Y.K. microRNA/Argonaute2 regulates nonsense-mediated messenger RNA decay. EMBO Rep. 2010, 11:380-386.
48. Hayashida Y., Nishibu T., Inoue K., Kurokawa T. A useful approach to total analysis of RISC-associated RNA. BMC Res. Notes 2009, 2:169.
49. Carroll J.S., Munchel S.E., Weis K. The DExD/H box ATPase Dhh1 functions in translational repression, mRNA decay, and processing body dynamics. J. Cell Biol. 2011, 194:527-537.
50. Houseley J., Tollervey D. The many pathways of RNA degradation. Cell 2009, 136:763-776.
51. Truesdell S.S., Mortensen R.D., Seo M., Schroeder J.C., Lee J.H., LeTonqueze O., Vasudevan S. MicroRNA-mediated mRNA translation activation in quiescent cells and oocytes involves recruitment of a nuclear microRNP. Sci. Rep. 2012, 2:842.
52. Soderholm J.F., Bird S.L., Kalab P., Sampathkumar Y., Hasegawa K., Uehara-Bingen M., Weis K., Heald R. Importazole, a small molecule inhibitor of the transport receptor importin-β. ACS Chem. Biol. 2011, 6:700-708.
53. Tritschler F., Braun J.E., Motz C., Igreja C., Haas G., Truffault V., Izaurralde E., Weichenrieder O. DCP1 forms asymmetric trimers to assemble into active mRNA decapping complexes in metazoa. Proc. Natl. Acad. Sci. USA 2009, 106:21591-21596.
54. Braun J.E., Truffault V., Boland A., Huntzinger E., Chang C.T., Haas G., Weichenrieder O., Coles M., Izaurralde E. A direct interaction between DCP1 and XRN1 couples mRNA decapping to 5' exonucleolytic degradation. Nat. Struct. Mol. Biol. 2012, 19:1324-1331.
55. Wang X., Arai S., Song X., Reichart D., Du K., Pascual G., Tempst P., Rosenfeld M.G., Glass C.K., Kurokawa R. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008, 454:126-130.